Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125932161 | 12593216 | 1 | I | 201603 | 20160520 | 20160726 | 20160726 | PER | US-ABBVIE-16P-163-1634967-00 | ABBVIE | 58.79 | YR | M | Y | 79.45000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125932161 | 12593216 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | Y | UNKNOWN | 21402 | 112 | UG | TABLET | QD | |||||
| 125932161 | 12593216 | 2 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | ONE TABLET EVERY OTHER DAY ALTERNATING WITH SYNTHROID 100MCG | Y | UNKNOWN | 21402 | 112 | UG | TABLET | |||||
| 125932161 | 12593216 | 3 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | Y | UNKNOWN,UNKNOWN | 21402 | TABLET | QD | |||||||
| 125932161 | 12593216 | 4 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | ONE TABLET EVERY OTHER DAY ALTERNATING WITH SYNTHROID 112MCG | Y | UNKNOWN,UNKNOWN | 21402 | 100 | UG | TABLET | |||||
| 125932161 | 12593216 | 5 | SS | TESTOSTERONE. | TESTOSTERONE | 1 | Topical | 1 PERCENT GEL | UNKNOWN | 21015 | GEL | ||||||||
| 125932161 | 12593216 | 6 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
| 125932161 | 12593216 | 7 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 125932161 | 12593216 | 8 | C | TUMERIC | TURMERIC | 1 | 0 | ||||||||||||
| 125932161 | 12593216 | 9 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 125932161 | 12593216 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125932161 | 12593216 | 1 | Hypothyroidism |
| 125932161 | 12593216 | 3 | Hypothyroidism |
| 125932161 | 12593216 | 5 | Blood testosterone decreased |
| 125932161 | 12593216 | 6 | Arthralgia |
| 125932161 | 12593216 | 7 | Product used for unknown indication |
| 125932161 | 12593216 | 8 | Arthralgia |
| 125932161 | 12593216 | 9 | Product used for unknown indication |
| 125932161 | 12593216 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125932161 | 12593216 | Abdominal pain upper | |
| 125932161 | 12593216 | Anxiety | |
| 125932161 | 12593216 | Blood testosterone decreased | |
| 125932161 | 12593216 | Blood thyroid stimulating hormone decreased | |
| 125932161 | 12593216 | Fatigue | |
| 125932161 | 12593216 | Hot flush | |
| 125932161 | 12593216 | Impaired gastric emptying | |
| 125932161 | 12593216 | Insomnia | |
| 125932161 | 12593216 | Lethargy | |
| 125932161 | 12593216 | Psychomotor hyperactivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125932161 | 12593216 | 1 | 201604 | 0 | ||
| 125932161 | 12593216 | 2 | 201605 | 0 | ||
| 125932161 | 12593216 | 3 | 201604 | 201605 | 0 | |
| 125932161 | 12593216 | 4 | 201605 | 0 | ||
| 125932161 | 12593216 | 5 | 201603 | 0 |